Verona Pharma Plc ADR (VRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VRNA | AMGN | REGN | VRTX | GILD |
| Company | Verona Pharma Plc ADR | Amgen Inc | Regeneron Pharmaceuticals | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 30.54 | 334.58 | 1,151.10 | 486.42 | 83.06 |
| High | 30.54 | 334.58 | 1,151.10 | 487.23 | 83.34 |
| Low | 28.93 | 331.08 | 1,134.60 | 477.17 | 82.38 |
| Last | 28.98 | 331.82 | 1,140.06 | 478.00 | 83.20 |
| Change | -1.18 | -3.44 | -13.02 | -11.43 | +0.04 |
| % Change | -3.91% | -1.03% | -1.13% | -2.34% | +0.05% |
| Volume | 299,566 | 1,123,973 | 190,427 | 747,884 | 3,757,518 |
| 20-Day Average Volume | 1,013,743 | 1,690,010 | 401,410 | 955,935 | 5,987,381 |
| Previous Close | 30.16 | 335.26 | 1,153.08 | 489.43 | 83.16 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 27.82 | 328.98 | 1,169.59 | 480.76 | 79.18 |
| 20-Day Raw Stochastic | 72.07% | 68.75% | 27.11% | 42.92% | 83.46% |
| 20-Day Relative Strength | 62.19% | 54.23% | 50.58% | 49.18% | 70.64% |
| Weighted Alpha | +78.41 | +24.91 | +39.36 | +33.45 | +16.77 |
| Today's Opinion | 100% Buy | 88% Buy | 80% Buy | 40% Buy | 88% Buy |
| Previous Opinion | 100% Buy | 88% Buy | 80% Buy | 72% Buy | 88% Buy |
| Last Month's Opinion | 100% Buy | 72% Buy | 100% Buy | 56% Buy | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.39% since 09/10/24 | +0.86% since 09/10/24 | +0.30% since 09/10/24 | +1.46% since 09/10/24 | +2.09% since 09/10/24 |
| Low | 27.92 on 09/11/24 | 320.30 on 09/11/24 | 1,113.24 on 09/11/24 | 460.69 on 09/11/24 | 79.64 on 09/11/24 |
| High | 30.73 on 09/12/24 | 337.56 on 09/16/24 | 1,170.58 on 09/13/24 | 490.15 on 09/16/24 | 84.89 on 09/12/24 |
| 1-Month | |||||
| %Chg | +5.46% since 08/16/24 | +3.21% since 08/16/24 | -3.35% since 08/16/24 | +0.06% since 08/16/24 | +12.69% since 08/16/24 |
| Low | 24.50 on 09/05/24 | 319.00 on 09/06/24 | 1,113.24 on 09/11/24 | 460.69 on 09/11/24 | 73.27 on 08/19/24 |
| High | 30.73 on 09/12/24 | 337.56 on 09/16/24 | 1,211.20 on 08/27/24 | 500.25 on 08/30/24 | 84.89 on 09/12/24 |
| 3-Month | |||||
| %Chg | +74.01% since 06/17/24 | +9.39% since 06/17/24 | +9.03% since 06/17/24 | +0.84% since 06/17/24 | +29.37% since 06/17/24 |
| Low | 14.14 on 06/28/24 | 302.02 on 06/18/24 | 1,011.67 on 07/03/24 | 458.04 on 08/13/24 | 62.69 on 06/18/24 |
| High | 30.73 on 09/12/24 | 346.85 on 07/25/24 | 1,211.20 on 08/27/24 | 510.64 on 08/01/24 | 84.89 on 09/12/24 |
| 6-Month | |||||
| %Chg | +85.24% since 03/15/24 | +23.39% since 03/15/24 | +18.18% since 03/15/24 | +17.17% since 03/15/24 | +12.83% since 03/15/24 |
| Low | 11.39 on 05/30/24 | 260.68 on 04/19/24 | 875.22 on 04/26/24 | 391.01 on 04/18/24 | 62.07 on 05/31/24 |
| High | 30.73 on 09/12/24 | 346.85 on 07/25/24 | 1,211.20 on 08/27/24 | 510.64 on 08/01/24 | 84.89 on 09/12/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,410,991 | 179,845,200 | 127,053,264 | 126,298,880 | 103,605,136 |
| Shares Outstanding, K | 79,940 | 536,435 | 110,186 | 258,053 | 1,245,853 |
| Annual Sales | 0 | 28,190,000,000 | 13,117,200,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | -54,370,000 | 6,717,000,000 | 3,953,600,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | 0 | 8,388,000,000 | 3,547,100,000 | 2,645,600,000 | 6,954,000,000 |
| Last Quarter Net Income | -70,840,000 | 746,000,000 | 1,432,300,000 | -3,593,600,000 | 1,614,000,000 |
| 60-Month Beta | 0.44 | 0.61 | 0.12 | 0.40 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.88 on 08/08/24 | 4.97 on 08/06/24 | 11.56 on 08/01/24 | -12.83 on 08/01/24 | 2.01 on 08/08/24 |
| Latest Earnings Date | 11/07/24 | 10/29/24 | 11/07/24 | 11/04/24 | 11/05/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | N/A | N/A | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 08/16/24 | N/A | N/A | 09/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.87 | 30.02 | 0.00 | 17.62 |